These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study]. Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C; Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051 [TBL] [Abstract][Full Text] [Related]
5. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics]. Jahnz-Rózyk K Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004 [TBL] [Abstract][Full Text] [Related]
6. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria]. Führlinger S Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765 [TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic review of medical management of persistent asthma. Cheng JW; Arnold RJ Allergy Asthma Proc; 2008; 29(2):109-22. PubMed ID: 18430307 [TBL] [Abstract][Full Text] [Related]
8. [The pharmacoeconomics of asthma]. Plaza Moral V Arch Bronconeumol; 1999 May; 35 Suppl 3():22-6. PubMed ID: 10410220 [No Abstract] [Full Text] [Related]
9. Direct and indirect costs of asthma in Canada, 1990. Krahn MD; Berka C; Langlois P; Detsky AS CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics of asthma treatment. Cleland J; Thomas M; Price D Expert Opin Pharmacother; 2003 Mar; 4(3):311-8. PubMed ID: 12614183 [TBL] [Abstract][Full Text] [Related]
11. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs. Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831 [TBL] [Abstract][Full Text] [Related]
12. The Cost of Asthma Treatment in Phramongkutlao Hospital: Population-Based Study in Adults. Boonpiyathad T; Yimsawad S; Sangasapaviriya A J Med Assoc Thai; 2016 Jan; 99(1):51-7. PubMed ID: 27455824 [TBL] [Abstract][Full Text] [Related]
13. [Direct cost of medical treatment to the asthmatic patient in the pediatric emergency service of a medical care tier-two hospital]. Ceballos Martínez ZI; González Mercado E; Jiménez Grandes I; Peralta Bahena ME; Tah Arias WF Rev Alerg Mex; 2003; 50(2):43-7. PubMed ID: 12825487 [TBL] [Abstract][Full Text] [Related]
14. Measuring costs and consequences in economic evaluation in asthma. Sculpher MJ; Price M Respir Med; 2003 May; 97(5):508-20. PubMed ID: 12735668 [TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement]. Hoomans T; van der Roer N; Severens JL; Delwel GO Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045 [TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomics. Ahuja J; Gupta M; Gupta AK; Kohli K Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600 [TBL] [Abstract][Full Text] [Related]
19. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Piecoro LT; Potoski M; Talbert JC; Doherty DE Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817 [TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomics of Biologic Therapy. Bukstein DA; Luskin AT Immunol Allergy Clin North Am; 2017 May; 37(2):413-430. PubMed ID: 28366485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]